Martingale Asset Management »

Beam Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $235k 12k 19.53
2024-12-31 $284k 11k 24.80
2024-09-30 $258k 11k 24.50
2024-06-30 $209k 8.9k 23.43